AIIMS, CSIR join hands to advance medical research, healthcare delivery

Published On 2024-12-22 11:00 GMT   |   Update On 2024-12-22 11:00 GMT

New Delhi: The Council of Scientific and Industrial Research (CSIR), New Delhi and All India Institute of Medical Sciences (AIIMS), New Delhi signed a Memorandum of Understanding (MoU) on December 17, 2024, at AIIMS, New Delhi aimed to provide a formal basis for initiating interaction between the two organizations to harness their respective strengths to advance medical research, enhance healthcare delivery, and tackle critical health challenges in India through the collaboration.

This strategic partnership marks a significant step forward in leveraging combined expertise and resources to address critical healthcare challenges and innovate solutions for improved patient outcomes.

During the event, under the Umbrella MoU between CSIR and AIIMS, another MoU was signed between CSIR’s Centre for Cellular & Molecular Biology (CSIR-CCMB), Hyderabad and AIIMS, New Delhi for focused research projects and to extend the use of facilities at CSIR-CCMB to AIIMS.

The MoUs were signed in the presence of Prof M Srinivas, Director, AIIMS, CSIR lab Directors of Institutes under the Healthcare theme, Senior officials of CSIR Hqrs as well as Senior faculty & Heads of different Departments at AIIMS.

Also Read:AIIMS signs MoU with Wipro GE Healthcare to set up AI health innovation hub

Speaking at the signing ceremony, Prof. M. Srinivas, Director, AIIMS, New Delhi added, “We are excited about the potential of this partnership. Together, we can explore new frontiers in healthcare research and ensure that our findings lead to real-world applications that improve patient care.”

At the event, Dr Vinay Nandicoori, Director CSIR-CCMB and Theme Director, Healthcare Theme of CSIR, presented the knowledgebase and developments involving nearly 15 out of 37 CSIR labs in areas such as affordable healthcare, drug development, per-clinical studies, surveillance activity of waste water, animal health, cannabis research, MTCC, infectious disease research, resourceful utilization of biomedical waste, early cancer detection, development of diagnostic and therapeutic devices, application of AI in medicine, ongoing R&D on sickle cell anemia, Phenome India COHORT of CSIR and more.

In an interactive session, faculty & heads from Departments of Endocrinology, Neurology, Gastroenterology, Biochemistry, Pulmonary Medicine and Cardiology of AIIMS presented the prospective areas of R&D and possible collaborations. Directors of CSIR Labs informed the available research potentials in the CSIR labs and detailed their area of interest for collaboration.

Through the MoU, CSIR and AIIMS strive to establish a synergistic partnership aimed at propelling medical research forward, enhancing healthcare delivery, and tackling pressing health challenges in India through joint research initiatives, knowledge sharing, innovation development, training and capacity building etc., leveraging the combined expertise of CSIR's scientific research and AIIMS's clinical insights. Joint development of new medical technologies, devices, and diagnostics are envisaged.

Both organizations are dedicated to promote ethical research practices and ensuring that all collaborative efforts are aligned with the highest standards of integrity and scientific rigor. The MoU set the foundation for ongoing collaboration and is expected to yield valuable insights and advancements in the healthcare sector.

Also Read:Garbage Spills Near AIIMS: Delhi Pollution Control Committee Raises Concern

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News